The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Nonviral delivery of synthetic siRNAs in vivo
Open accessAbstract
Sequence-specific gene silencing using small interfering RNA (siRNA) is a Nobel prize-winning technology that is now being evaluated in clinical trials as a potentially novel therapeutic strategy. This article provides an overview of the major pharmaceutical challenges facing siRNA therapeutics, focusing on the delivery strategies for synthetic siRNA duplexes in vivo, as this remains one of the most important issues to be resolved. This article also highlights the importance of understanding the genocompatibility/toxicogenomics of siRNA delivery reagents in terms of their impact on gene-silencing activity and specificity. Collectively, this information is essential for the selection of optimally acting siRNA delivery system combinations for the many proposed applications of RNA interference.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
TOLENTINO, M. J., BRUCKER, A. J., FOSNOT, J., YING, G.-S., WU, I.-H., MALIK, G., WAN, S., & REICH, S. J. (2004) · RETINA · doi:10.1097/00006982-200402000-00018 · Cited by 172
RetractedPotent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755
Asymmetry in the Assembly of the RNAi Enzyme Complex
Schwarz, D. S., Hutvágner, G., Du, T., Xu, Z., Aronin, N., & Zamore, P. D. (2003) · Cell · doi:10.1016/s0092-8674(03)00759-1 · Cited by 2,922
Functional siRNAs and miRNAs exhibit strand bias
Khvorova, A., Reynolds, A., & Jayasena, S. D. (2003) · Cell · doi:10.1016/s0092-8674(03)00801-8 · Cited by 2,645
Expression profiling reveals off-target gene regulation by RNAi
Jackson, A. L., Bartz, S. R., Schelter, J., Kobayashi, S. V., Burchard, J., Mao, M., Li, B., Cavet, G., & Linsley, P. S. (2003) · Nature Biotechnology · doi:10.1038/nbt831 · Cited by 2,370
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,183
Rational siRNA design for RNA interference
Reynolds, A., Leake, D., Boese, Q., Scaringe, S., Marshall, W. S., & Khvorova, A. (2004) · Nature Biotechnology · doi:10.1038/nbt936 · Cited by 2,094
Exploiting the enhanced permeability and retention effect for tumor targeting
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846
Single-Stranded Antisense siRNAs Guide Target RNA Cleavage in RNAi
Martinez, J., Patkaniowska, A., Urlaub, H., Lührmann, R., & Tuschl, T. (2002) · Cell · doi:10.1016/s0092-8674(02)00908-x · Cited by 1,459
Activation of the interferon system by short-interfering RNAs
Sledz, C. A., Holko, M., de Veer, M. J., Silverman, R. H., & Williams, B. R. G. (2003) · Nature Cell Biology · doi:10.1038/ncb1038 · Cited by 1,400
RNAi-mediated gene silencing in non-human primates
Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
Judge, A. D., Sood, V., Shaw, J. R., Fang, D., McClintock, K., & MacLachlan, I. (2005) · Nature Biotechnology · doi:10.1038/nbt1081 · Cited by 1,250
Transvascular delivery of small interfering RNA to the central nervous system
Kumar, P., Wu, H., McBride, J. L., Jung, K.-E., Hee Kim, M., Davidson, B. L., Kyung Lee, S., Shankar, P., & Manjunath, N. (2007) · Nature · doi:10.1038/nature05901 · Cited by 1,246
Interfering with disease: a progress report on siRNA-based therapeutics
de Fougerolles, A., Vornlocher, H.-P., Maraganore, J., & Lieberman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2310 · Cited by 1,203
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
Morrissey, D. V., Lockridge, J. A., Shaw, L., Blanchard, K., Jensen, K., Breen, W., Hartsough, K., Machemer, L., Radka, S., Jadhav, V., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1122 · Cited by 1,168
RNA interference targeting Fas protects mice from fulminant hepatitis
Song, E., Lee, S.-K., Wang, J., Ince, N., Ouyang, N., Min, J., Chen, J., Shankar, P., & Lieberman, J. (2003) · Nature Medicine · doi:10.1038/nm828 · Cited by 1,110
RNAi therapeutics: a potential new class of pharmaceutical drugs
Bumcrot, D., Manoharan, M., Koteliansky, V., & Sah, D. W. Y. (2006) · Nature Chemical Biology · doi:10.1038/nchembio839 · Cited by 1,085
Strategies for silencing human disease using RNA interference
Kim, D. H., & Rossi, J. J. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2006 · Cited by 1,078
Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors
Song, E., Zhu, P., Lee, S.-K., Chowdhury, D., Kussman, S., Dykxhoorn, D. M., Feng, Y., Palliser, D., Weiner, D. B., Shankar, P., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1101 · Cited by 1,021
Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras
McNamara, J. O., Andrechek, E. R., Wang, Y., Viles, K. D., Rempel, R. E., Gilboa, E., Sullenger, B. A., & Giangrande, P. H. (2006) · Nature Biotechnology · doi:10.1038/nbt1223 · Cited by 1,002
Widespread siRNA “off-target” transcript silencing mediated by seed region sequence complementarity
Jackson, A. L., Burchard, J., Schelter, J., Chau, B. N., Cleary, M., Lim, L., & Linsley, P. S. (2006) · RNA · doi:10.1261/rna.25706 · Cited by 956
3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets
Birmingham, A., Anderson, E. M., Reynolds, A., Ilsley-Tyree, D., Leake, D., Fedorov, Y., Baskerville, S., Maksimova, E., Robinson, K., Karpilow, J., et al. (2006) · Nature Methods · doi:10.1038/nmeth854 · Cited by 920
Schiffelers, R. M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh140 · Cited by 901
RNAi therapeutics: Principles, prospects and challenges
Aagaard, L., & Rossi, J. J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.005 · Cited by 895
Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing
Jackson, A. L., Burchard, J., Leake, D., Reynolds, A., Schelter, J., Guo, J., Johnson, J. M., Lim, L., Karpilow, J., Nichols, K., et al. (2006) · RNA · doi:10.1261/rna.30706 · Cited by 789
Inhibition of respiratory viruses by nasally administered siRNA
Bitko, V., Musiyenko, A., Shulyayeva, O., & Barik, S. (2005) · Nature Medicine · doi:10.1038/nm1164 · Cited by 725
Urban-Klein, B., Werth, S., Abuharbeid, S., Czubayko, F., & Aigner, A. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302425 · Cited by 716
In vivo imaging of siRNA delivery and silencing in tumors
Medarova, Z., Pham, W., Farrar, C., Petkova, V., & Moore, A. (2007) · Nature Medicine · doi:10.1038/nm1486 · Cited by 697
Design and gene delivery activity of modified polyethylenimines
Kircheis, R., Wightman, L., & Wagner, E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00202-2 · Cited by 651
Lipid-based Nanoparticles for Nucleic Acid Delivery
Li, W., & Szoka, F. C. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9180-5 · Cited by 641
Bartlett, D. W. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj439 · Cited by 592
RNA Interference in Vitro and in Vivo Using a Novel Chitosan/siRNA Nanoparticle System
Howard, K. A., Rahbek, U. L., Liu, X., Damgaard, C. K., Glud, S. Z., Andersen, M. Ø., Hovgaard, M. B., Schmitz, A., Nyengaard, J. R., Besenbacher, F., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.04.010 · Cited by 585
Hu-Lieskovan, S., Heidel, J. D., Bartlett, D. W., Davis, M. E., & Triche, T. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0565 · Cited by 567
Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging
Tomalia, D. A., Reyna, L. A., & Svenson, S. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350061 · Cited by 496
Off-target effects by siRNA can induce toxic phenotype
Fedorov, Y., Anderson, E. M., Birmingham, A., Reynolds, A., Karpilow, J., Robinson, K., Leake, D., Marshall, W. S., & Khvorova, A. (2006) · RNA · doi:10.1261/rna.28106 · Cited by 490
Gene Silencing by Systemic Delivery of Synthetic siRNAs in Adult Mice
Sørensen, D. R., Leirdal, M., & Sioud, M. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00181-5 · Cited by 464
Inhibition of influenza virus production in virus-infected mice by RNA interference
Ge, Q., Filip, L., Bai, A., Nguyen, T., Eisen, H. N., & Chen, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402486101 · Cited by 444
Reich, S. J., Fosnot, J., Kuroki, A. M., Tang, W., Yang, X., Maguire, A. M., Bennett, J., & Tolentino, M. J. (2003) · PubMed · Cited by 441
Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque
Li, B.-J., Tang, Q., Cheng, D., Qin, C., Xie, F. Y., Wei, Q., Xu, J., Liu, Y., Zheng, B.-J., Woodle, M. C., et al. (2005) · Nature Medicine · doi:10.1038/nm1280 · Cited by 433
An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection
Palliser, D., Chowdhury, D., Wang, Q.-Y., Lee, S. J., Bronson, R. T., Knipe, D. M., & Lieberman, J. (2006) · Nature · doi:10.1038/nature04263 · Cited by 410
PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner
Ishida, T., Wang, X., Shimizu, T., Nawata, K., & Kiwada, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.015 · Cited by 382
RNA interference: From gene silencing to gene-specific therapeutics
Leung, R. K. M., & Whittaker, P. A. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.03.004 · Cited by 382
Heidel, J. D., Yu, Z., Liu, J. Y.-C., Rele, S. M., Liang, Y., Zeidan, R. K., Kornbrust, D. J., & Davis, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701458104 · Cited by 382
siRNA relieves chronic neuropathic pain
Dorn, G. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh044 · Cited by 381
A Small Interfering RNA Targeting Vascular Endothelial Growth Factor as Cancer Therapeutics
Takei, Y., Kadomatsu, K., Yuzawa, Y., Matsuo, S., & Muramatsu, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2682 · Cited by 378
A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium
Santel, A., Aleku, M., Keil, O., Endruschat, J., Esche, V, Fisch, G., Dames, S., Löffler, K., Fechtner, M., Arnold, W., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302777 · Cited by 368
siRNA-mediated off-target gene silencing triggered by a 7 nt complementation
Lin, X. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki762 · Cited by 368
Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo
Takeshita, F., Minakuchi, Y., Nagahara, S., Honma, K., Sasaki, H., Hirai, K., Teratani, T., Namatame, N., Yamamoto, Y., Hanai, K., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501753102 · Cited by 355
Radiolabeled Multimeric Cyclic RGD Peptides as Integrin αvβ3Targeted Radiotracers for Tumor Imaging
Liu, S. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060049x · Cited by 340
Minakuchi, Y. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh093 · Cited by 336
Verma, U. N., Surabhi, R. M., Schmaltieg, A., Becerra, C. R., & Gaynor, R. B. (2003) · PubMed · Cited by 328
Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides.
Beltinger, C., Saragovi, H. U., Smith, R. M., LeSauteur, L., Shah, N., DeDionisio, L., Christensen, L., Raible, A., Jarett, L., & Gewirtz, A. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117860 · Cited by 312
Small interfering RNA Inhibits Hepatitis B virus replication in mice
Giladi, H., Ketzinel-Gilad, M., Rivkin, L., Felig, Y., Nussbaum, O., & Galun, E. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00244-2 · Cited by 306
Halder, J., Kamat, A. A., Landen, C. N., Han, L. Y., Lutgendorf, S. K., Lin, Y. G., Merritt, W. M., Jennings, N. B., Chavez-Reyes, A., Coleman, R. L., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0021 · Cited by 297
Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication†
Morrissey, D. V., Blanchard, K., Shaw, L., Jensen, K., Lockridge, J. A., Dickinson, B., McSwiggen, J. A., Vargeese, C., Bowman, K., Shaffer, C. S., et al. (2005) · Hepatology · doi:10.1002/hep.20702 · Cited by 290
Lessons from Nature: microRNA-based shRNA libraries
Chang, K., Elledge, S. J., & Hannon, G. J. (2006) · Nature Methods · doi:10.1038/nmeth923 · Cited by 282
Peer, D., Zhu, P., Carman, C. V., Lieberman, J., & Shimaoka, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608491104 · Cited by 275
Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides
Meade, B. R., & Dowdy, S. F. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.004 · Cited by 274
Gene transfer with modified polyethylenimines
Kichler, A. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.507 · Cited by 265
Pillé, J.-Y., Denoyelle, C., Varet, J., Bertrand, J.-R., Soria, J., Opolon, P., Lu, H., Pritchard, L.-L., Vannier, J.-P., Malvy, C., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.08.029 · Cited by 263
Geisbert, T. W., Hensley, L. E., Kagan, E., Yu, E. Z., Geisbert, J. B., Daddario‐DiCaprio, K., Fritz, E. A., Jahrling, P. B., McClintock, K., Phelps, J. R., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/504267 · Cited by 254
Filleur, S., Courtin, A., Ait‐Si‐Ali, S., Guglielmi, J., Arnold, C., Harel‐Bellan, A., Clézardin, P., & Cabon, F. (2003) · PubMed · Cited by 253
Kim, W. J., Christensen, L. V., Jo, S., Yockman, J. W., Jeong, J. H., Kim, Y.-H., & Kim, S. W. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.022 · Cited by 251
Biodistribution of phosphodiester and phosphorothioate siRNA
Braasch, D. A., Paroo, Z., Constantinescu, A., Ren, G., Öz, O. K., Mason, R. P., & Corey, D. R. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.12.074 · Cited by 251
Zhang, X., Shan, P., Jiang, D., Noble, P. W., Abraham, N. G., Kappas, A., & Lee, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312941200 · Cited by 241
Therapeutic potential of RNA interference against cancer
Takeshita, F., & Ochiya, T. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00234.x · Cited by 236
Tan, P.-H., Yang, L.-C., Shih, H.-C., Lan, K.-C., & Cheng, J.-T. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302376 · Cited by 222
Akhtar, S., & Benter, I. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.010 · Cited by 219
Self-citationvan de Water, F. M., Boerman, O. C., Wouterse, A. C., Peters, J. G. P., Russel, F. G. M., & Masereeuw, R. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.009555 · Cited by 217
The delivery of antisense therapeutics
Akhtar, S., Hughes, M. D., Khan, A., Bibby, M., Hussain, M., Nawaz, Q., Double, J., & Sayyed, P. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00080-6 · Cited by 215
Self-citationSemple, S. C., Harasym, T. O., Clow, K. A., Ansell, S. M., Klimuk, S. K., & Hope, M. J. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078113 · Cited by 211
Thakker, D. R., Natt, F., Hüsken, D., Maier, R., Müller, M., van der Putten, H., Hoyer, D., & Cryan, J. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406214101 · Cited by 211
Polymer genomics: An insight into pharmacology and toxicology of nanomedicines☆
KABANOV, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.019 · Cited by 204
Tat-Conjugated PAMAM Dendrimers as Delivery Agents for Antisense and siRNA Oligonucleotides
Kang, H., DeLong, R., Fisher, M. H., & Juliano, R. L. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-8330-5 · Cited by 198
Hassani, Z., Lemkine, G. F., Erbacher, P., Palmier, K., Alfama, G., Giovannangeli, C., Behr, J.-P., & Demeneix, B. A. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.659 · Cited by 198
In vivo studies with antisense oligonucleotides
Akhtar, S., & Agrawal, S. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(96)01002-4 · Cited by 195
Self-citationTherapeutic potential for microRNAs
Esau, C. C., & Monia, B. P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.007 · Cited by 195
Materializing the Potential of Small Interfering RNA via a Tumor-Targeting Nanodelivery System
Pirollo, K. F., Rait, A., Zhou, Q., Hwang, S. H., Dagata, J. A., Zon, G., Hogrefe, R. I., Palchik, G., & Chang, E. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4535 · Cited by 195
Argonaute: a scaffold for the function of short regulatory RNAs
Parker, J. S., & Barford, D. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.09.010 · Cited by 180
Tsubouchi, A., Sakakura, J., Yagi, R., Mazaki, Y., Schaefer, E., Yano, H., & Sabe, H. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200202117 · Cited by 177
shRNA and siRNA delivery to the brain
Pardridge, W. M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.008 · Cited by 176
Harnessing in vivo siRNA delivery for drug discovery and therapeutic development
Xie, F. Y., Woodle, M. C., & Lu, P. Y. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03668-8 · Cited by 174
Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA
Klein, C., Bock, C. T., Wedemeyer, H., Wüstefeld, T., Locarnini, S., Dienes, H. P., Kubicka, S., Manns, M. P., & Trautwein, C. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00720-0 · Cited by 174
Applications of RNA Interference in Mammalian Systems
Martin, S. E., & Caplen, N. J. (2007) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.8.080706.092424 · Cited by 158
Nanomedicine: Techniques, Potentials, and Ethical Implications
Ebbesen, M., & Jensen, T. G. (2006) · BioMed Research International · doi:10.1155/jbb/2006/51516 · Cited by 155
Chien, P.-Y., Wang, J., Carbonaro, D., Lei, S., Miller, B., Sheikh, S., Ali, S. M., Ahmad, M. U., & Ahmad, I. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700793 · Cited by 152
Omidi, Y., Hollins, A. J., Benboubetra, M., Drayton, R. M., Benter, I. F., & Akhtar, S. (2003) · Journal of drug targeting · doi:10.1080/10611860310001636908 · Cited by 152
Self-citationMakimura, H., Mizuno, T. M., Mastaitis, J. W., Agami, R., & Mobbs, C. V. (2002) · BMC Neuroscience · doi:10.1186/1471-2202-3-18 · Cited by 150
Omidi, Y., Hollins, A. J., Drayton, R. M., & Akhtar, S. (2005) · Journal of drug targeting · doi:10.1080/10611860500418881 · Cited by 143
Self-citationKhan, A., Benboubetra, M., Sayyed, P. Z., Ng, K. W., Fox, S. P., Beck, G., Benter, I. F., & Akhtar, S. (2004) · Journal of drug targeting · doi:10.1080/10611860400003858 · Cited by 134
Self-citationDelivery Systems for the Direct Application of siRNAs to Induce RNA Interference (RNAi) In Vivo
Aigner, A. M. (2006) · BioMed Research International · doi:10.1155/jbb/2006/71659 · Cited by 132
Nakamura, H., Siddiqui, S. S., Shen, X., Malik, A. B., Pulido, J. S., Kumar, N. M., & Yue, B. Y. J. T. (2004) · PubMed · Cited by 130
Erbin Suppresses the MAP Kinase Pathway
Huang, Y. Z., Zang, M., Xiong, W., Luo, Z., & Mei, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m205413200 · Cited by 125
Hollins, A. J., Omidi, Y., Benter, I. F., & Akhtar, S. (2007) · Journal of drug targeting · doi:10.1080/10611860601151860 · Cited by 117
Self-citationRNAi-Induced Gene Silencing by Local Electroporation in Targeting Brain Region
Akaneya, Y., Jiang, B., & Tsumoto, T. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00161.2004 · Cited by 115
The cellular delivery of antisense oligonucleotides and ribozymes
Hughes, M. D., Hussain, M., Nawaz, Q., Sayyed, P. Z., & Akhtar, S. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(00)00326-3 · Cited by 111
Self-citationInhibition of gene expression in mice muscle by in vivo electrically mediated siRNA delivery
Golzio, M., Mazzolini, L., Moller, P., Rols, M., & Teissié, J. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302405 · Cited by 110
Sebestyén, M. G., Budker, V. G., Budker, T., Subbotin, V. M., Zhang, G., Monahan, S. D., Lewis, D. L., Wong, S. C., Hagstrom, J. E., & Wolff, J. A. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.921 · Cited by 106
Pal, A., Ahmad, A., Khan, S., Sakabe, I., Zhang, C., Kasid, U. N., & Ahmad, I. (2005) · International Journal of Oncology · doi:10.3892/ijo.26.4.1087 · Cited by 104
Targeted Delivery Systems of Small Interfering RNA by Systemic Administration
Kawakami, S., & Hashida, M. (2007) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.22.142 · Cited by 104
PAMAM Dendrimers as Delivery Agents for Antisense Oligonucleotides
Yoo, H., Sazani, P., & Juliano, R. L. (1999) · Pharmaceutical Research · doi:10.1023/a:1018926605871 · Cited by 103
MicroRNA therapeutics: a new niche for antisense nucleic acids
Hammond, S. M. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.01.004 · Cited by 101
Delivery Strategies for siRNA-mediated Gene Silencing
Gilmore, I. R., Fox, S. P., Hollins, A. J., et al. (2006) · Current Drug Delivery · doi:10.2174/156720106776359159 · Cited by 99
Non-viral siRNA delivery to the lung
Thomas, M., Lu, J. J.-Q., Chen, J., & Klibanov, A. M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.003 · Cited by 95
Efficient siRNA delivery using water soluble lipopolymer for anti-angiogenic gene therapy
Kim, W. J., Chang, C., Lee, M., & Kim, S. W. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.12.026 · Cited by 95
The Design and Exogenous Delivery of siRNA for Post-transcriptional Gene Silencing
Gilmore, I. R., Fox, S. P., Hollins, A. J., Sohail, M. F., & Akhtar, S. (2004) · Journal of drug targeting · doi:10.1080/10611860400006257 · Cited by 84
Self-citationSystemic siRNA delivery via hydrodynamic intravascular injection
Lewis, D. L., & Wolff, J. A. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.002 · Cited by 83
Kishida, T., Asada, H., Gojo, S., Ohashi, S., Shin‐Ya, M., Yasutomi, K., Terauchi, R., Takahashi, K. A., Kubo, T., Imanishi, J., et al. (2003) · The Journal of Gene Medicine · doi:10.1002/jgm.456 · Cited by 78
Different delivery methods—different expression profiles
Federov, Y., KING, A. D., Anderson, E. M., Karpilow, J. M., Ilsley, D. D., Marshall, W., & Khvorova, A. (2005) · Nature Methods · doi:10.1038/nmeth0405-241 · Cited by 78
Noninvasive delivery of small inhibitory RNA and other reagents to pulmonary alveoli in mice
Massaro, D. J., MASSARO, G. D., & Clerch, L. B. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00067.2004 · Cited by 74
siRNA targeted against amyloid precursor protein impairs synaptic activity in vivo
Hérard, A., Besret, L., Dubois, A., Dauguet, J., Delzescaux, T., Hantraye, P., Bonvento, G., & Moya, K. L. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.10.020 · Cited by 67
Shishkina, G. T., Kalinina, T. S., & Дыгало, Н. Н. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.015 · Cited by 66
Development of new RNAi therapeutics.
Liu, G., Wong‐Staal, F., & Li, Q.-X. (2007) · PubMed · doi:10.14670/hh-22.211 · Cited by 59
Non-viral cancer gene therapy: Beyond delivery
Akhtar, S. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302692 · Cited by 56
Self-citationBeale, G., Hollins, A. J., Benboubetra, M., Sohail, M. F., Fox, S. P., Benter, I. F., & Akhtar, S. (2003) · Journal of drug targeting · doi:10.1080/1061186042000207039 · Cited by 52
Self-citationArnold, A., Tang, Y., Qian, K., Shen, L., Valencia, V., Phillips, M. I., & Zhang, Y. C. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000254374.73241.ab · Cited by 47
Intracellular Delivery of Oligonucleotide Conjugates and Dendrimer Complexes
Juliano, R. L. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1348.011 · Cited by 46
Nonviral delivery vehicles for use in short hairpin RNA-based cancer therapies
Vorhies, J. S., & Nemunaitis, J. J. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.3.373 · Cited by 43
Kühn, R., Streif, S., & Wurst, W. (2007) · Springer eBooks · doi:10.1007/978-3-540-35109-2_7 · Cited by 31
Lipid-Protamine-DNA-Mediated Antigen Delivery
Vangasseri, D., Han, S., & Huang, L. (2005) · Current Drug Delivery · doi:10.2174/156720105774370168 · Cited by 31
Interaction of oligonucleotide-conjugates with the dipeptide transporter system in CACO-2 cells
Moore, V., Dunnion, D. J., Brown, T. P., Irwin, W. J., & Akhtar, S. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00862-3 · Cited by 13
Self-citation
Cited by
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rupaimoole, R., & Slack, F. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.246 · Cited by 4,741
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115
The current state and future directions of RNAi-based therapeutics
Setten, R. L., Rossi, J. J., & Han, S.-P. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0017-4 · Cited by 1,443
Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo
Jayaraman, M., Ansell, S. M., Mui, B. L., Tam, Y. K., Chen, J., Du, X., Butler, D., Eltepu, L., Matsuda, S., Narayanannair, J. K., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203263 · Cited by 1,267
Delivery of siRNA Therapeutics: Barriers and Carriers
Wang, J., Lu, Z., Wientjes, M. G., & Au, J. L.-S. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9210-4 · Cited by 798
Metadata
- Authors
- Akhtar, S., & Benter, I. F.
- Venue
- Journal of Clinical Investigation
- Published
- 2007-12-03
- Volume
- 117
- Issue
- 12
- Pages
- 3623-3632
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2015729243
- Cited by
- 464
- References
- 122
- FWCI
- 13.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.